Press release
Animal Nutrition
February 9, 2023

Evonik Animal Nutrition to showcase methionine production expansion at IPPE 2023

  • New methyl mercaptan production plant in Mobile, Alabama, to come on stream in 2024
  • Backwards integrated plant to strengthen supply security for Evonik customers
  • Evonik’s commitment to sustainability to be center stage at IPPE

Essen, Germany. Evonik Animal Nutrition will showcase the US expansion of its global methionine production network at the upcoming International Production & Processing Expo (IPPE), in Atlanta, Georgia, United States. Its new methyl mercaptan production plant in Mobile, Alabama, is due to come on stream in 2024.

With the backward integration into methyl mercaptan, Evonik will be able to produce all necessary intermediates for its methionine production in Mobile itself – as is already the case in Evonik’s other global methionine hubs in Antwerp and Singapore. This investment serves the expanding global market for DL- methionine, underlining Evonik’s clear commitment to the industry.

“This backward integration makes us more independent of fragile supply chains, guaranteeing that all-important supply security for our customers in the Americas, as well as globally,” says Gaetano Blanda, head of Animal Nutrition business line. “It also strengthens our leading cost position and makes it easier for us to boost future capacity for methionine to grow with our customers. We’re looking forward to discussing this and more at IPPE.”

Methyl mercaptan is an important intermediate in the production of DL-methionine (MetAMINO®) which helps livestock farmers to feed their animals efficiently, healthily and sustainably.

Evonik Animal Nutrition’s focus on sustainability – which has recently seen the launch of its new “Sciencing Podcast” – will be center stage at the three-day event. Director of Sustainability, Faazi Adam, will be leading a panel discussion, presented by Watt Global Media, on “Net zero and the future of sustainable poultry production”, on January 24.

At the booth, Evonik will unveil its science-based inoSust® sustainability concept, designed to help customers address sustainability challenges and boost productivity and profitability. Part of Evonik’s inoSust® offering will be Opteinics™, a digital tool developed by BASF, to help customers assess and measure the environmental footprint of animal feed.

The Evonik team will also be on hand to discuss the business line’s focus on “Sciencing the Global Food Challenge,” to achieve sustainable food production through its gut health solutions. Evonik’s Sustainable Livestock Farming portfolio helps farmers to improve the health and welfare of their animals.

IPPE, which runs from January 24-26, 2023, is a major event in the livestock industry’s calendar, bringing together experts to discuss the latest innovations and developments in the global animal food sector, and the solutions needed to meet the challenges it faces. The Evonik booth is located in Hall B, Stand B6927.

Company information

Evonik is one of the world leaders in specialty chemicals. The company is active in more than 100 countries around the world and generated sales of €15 billion and an operating profit (adjusted EBITDA) of €2.38 billion in 2021. Evonik goes far beyond chemistry to create innovative, profitable and sustainable solutions for customers. About 33,000 employees work together for a common purpose: We want to improve life today and tomorrow.

About Nutrition & Care

The focus of the business of the Nutrition & Care division is on health and quality of life. It develops differentiated solutions for active pharmaceutical ingredients, medical devices, nutrition for humans and animals, personal care, cosmetics, and household cleaning. In these resilient end markets, the division generated sales of €3.56 billion in 2021 with about 5,300 employees.


In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.